$NAGE
ChromaDex Corp.
CIK:0001386570|SEC Filings
Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| Sales, net | $ 29,785 | $ 31,117 | $ 61,259 | $ 61,598 |
| Cost of sales | 10,471 | 10,891 | 21,969 | 22,041 |
| Gross profit | 19,314 | 20,226 | 39,290 | 39,557 |
| Operating expenses: | ||||
| Sales and marketing | 10,130 | 8,207 | 19,805 | 16,324 |
| Research and development | 1,513 | 1,567 | 2,994 | 2,825 |
| General and administrative | 6,971 | 7,267 | 14,215 | 12,451 |
| Total operating expenses | 18,614 | 17,041 | 37,014 | 31,600 |
| Operating income | 700 | 3,185 | 2,276 | 7,957 |
| Nonoperating income: | ||||
| Interest income, net | 372 | 552 | 747 | 1,011 |
| Gain on sale of operating segment | (3) | 0 | 4,781 | 0 |
| Income before provision for income taxes | 1,069 | 3,737 | 7,804 | 8,968 |
| Provision for income taxes | 106 | 128 | 523 | 296 |
| Net income | $ 963 | $ 3,609 | $ 7,281 | $ 8,672 |
| Net income per share attributable to common stockholders: | ||||
| Basic (in dollar per share) | $ 0.01 | $ 0.05 | $ 0.09 | $ 0.11 |
| Diluted (in dollar per share) | $ 0.01 | $ 0.04 | $ 0.09 | $ 0.10 |
| Weighted average common shares outstanding: | ||||
| Basic (in shares) | 79,322 | 79,249 | 79,619 | 78,534 |
| Diluted (in shares) | 82,504 | 86,241 | 83,474 | 84,877 |